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ABSTRACT
Cellular communication occurs as a result of changes in signaling pathways.
A well-studied signaling pathway is through G protein coupled receptors (GPCRs).
In gonadotropes, GPCR stimulation by GnRH leads to the activation of protein kinase
A (PKA). Activated PKA can phosphorylate ion channels, potentially causing an
influx of calcium, depolarization and secretion of hormones. A scaffolding protein
known as AKAP150 anchors PKA near L-type calcium channels. In addition,
AKAP150 anchors phosphatases, which provides temporal control during signaling
events. It was recently shown that AKAP150 is mobile in neuronal dendrites,
providing regulation to where the signaling cascade occurs in the cell. It is not yet
known what AKAP150 binds to in gonadotropes or how it translocates. In order to
investigate the mobility of this protein in pituitary cells, a variety of methods were
used in this study. Time-lapse imaging and permeabilization assays suggested that
AKAP150-GFP was mobile in LβT2 cells, but more sensitive methods were needed
to study temporal and spatial resolution. Quantitative FRAP and FLIP analysis
provided strong qualitative evidence that AKAP150-GFP was mobile in LβT2 cells
and the protein moved laterally along the cell rim. Lastly, comparing rim intensity in
LβT2 cells immunostained for endogenous AKAP150 and actin indicated the
scaffolding protein could cluster with to actin.
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INTRODUCTION
Basic Hormone Function
One role of the endocrine system in the human body is to maintain body
homeostasis by signaling through hormones. Hormones are chemical signals that
help to coordinate the body’s functions. When released from a cell, peptide
hormones are secreted into the blood stream and control long lasting responses to
stimuli in the body. Examples of stimuli affecting the endocrine system include
dehydration, low blood glucose levels and an increase in heart rate and stress when
feeling threatened (Yeung et al. 2006). In addition to regulating the response to
specific stimuli, hormones control developmental processes such as distinct sexdriven appearances between adult males and females. Several disease states exist due
to an imbalance of hormones. A few of these diseases include diabetes mellitus,
hypopituitarism, Cushing syndrome and Graves’ disease. Peptide hormones are
composed of protein, peptides, or amines and are compacted in dense core vesicles
before being released into the blood stream. Such hormones are soluble in water and
are unable to pass through the cell membrane, thus requiring binding to a receptor on
the outside of the cell to relay the signal to inside of the cell (Yeung et al. 2006).
A structure in the brain that controls the pituitary endocrine system is the
hypothalamus. The hypothalamus receives signals from external and internal stimuli
before sending out neuronal or hormonal responses. The hypothalamus affects the
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endocrine system by directly stimulating or inhibiting the pituitary gland. The
pituitary gland is composed of an anterior and posterior lobe. The anterior lobe
contains endocrine cells and the posterior lobe is composed of nervous tissue and is
considered an extension of the hypothalamus (Davis et al. 2013). The hypothalamus
controls the anterior pituitary by using releasing and inhibiting hormones. The
releasing hormones stimulate the anterior pituitary to secrete one or more specific
hormones. The inhibiting hormones induce the anterior pituitary to stop secreting one
or more specific hormones (Yeung et al. 2006).
The anterior lobe of the pituitary is composed of five different endocrine cell
types that secrete hormones necessary for growth, development, metabolism and
sexual function. These cell types include thyrotropes, lactotropes, corticotropes,
somatotropes and gonadotropes (Ooi, Tawadros, and Escalona 2004). These cells
secrete hormones directly into the blood, which control the activity of other endocrine
glands and tissues.
Gonadotropes make up approximately 10-15% of the cell population in the
anterior pituitary and secrete the gonadotropin hormones, leutinizing hormone (LH)
and follicle-stimulating hormone (FSH). Gonadotropin secretion occurs when
gonadotropin-releasing hormone (GnRH), binds to a GnRH- receptor, causing an
increase in cytosolic calcium and secretion of LH and FSH (Ooi, Tawadros, and
Escalona 2004). LH and FSH affect reproduction function by acting on the gonads.
Once stimulated by LH or FSH, the ovaries and testes can then synthesize and secrete
estrogens, progestins and androgens (Yeung et al. 2006).
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LβT2 Gonadotrope cell line
In order to study gonadotropes as an isolated cell, several gonadotroph cell
lines have been created. The present research study utilized the LβT2 immortalized
cell line. The LβT2 cell line was created from pituitary tumors that developed in a
transgenic mouse using the SV 40 T-antigen driven by the rat LHβ gene promoter.
This cell line is considered an acceptable gonadotroph model because it expresses
mRNA for both LHα and LHβ subunits, which are markers of gonadotrope
differentiation (Ooi, Tawadros, and Escalona 2004). In addition, LβT2 cells express
mRNA for the GnRH receptor and secrete LH when GnRH is bound to the GnRH
receptor (Thomas et al. 1996). In addition, LH secretion is stimulated by
depolarization of these cells, which is another indicator of the cell responding in a
normal physiological manner.
In LβT2 cells, the GnRH receptor is a plasma membrane G protein coupled
receptor (GPCR) that interacts with heterotrimeric G proteins to initiate downstream
signaling (Liu et al. 2002). After the GTP-bound α subunit is released from the βδ
subunits of the heterotrimeric G protein, several second messenger signaling
molecules are activated. These molecules create an increase in intracellular
diacylglycerol (DAG) and calcium from phosphoinositide turnover as well as an
increase in intracellular cyclic adenosine monophosphate (cAMP) levels. The second
messenger molecules then activate down-stream kinases, such as protein kinase C
(PKC), protein kinase A (PKA), and calcium-dependent kinases (Liu et al. 2002).
Specifically, GnRH activates the ERK, c-Jun N-terminal and p38 MAPK families in
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LBetaT2 cells. GnRH also induces c-fos and LHβ protein expression in this cell line
(Liu et al. 2002). The stimulatory G proteins coupled to the GPCR when activated by
GnRH in LBetaT2 cells are Gαq/11 and Gαs. To verify that these proteins were
activated in LBetaT2 cells, recombinant adenovirus vectors expressing Gαq wildtype
or a constitutively active mutant (Q209L) Gαq were used to analyze for increased
ERK, c-Fos and LHβ protein expression. In the cells containing the constitutively
active mutant, c-Fos and LHβ protein expression was induced, but ERK was not. The
lack of ERK can be attributed to the protein becoming inactivated before expression
could be detected. In addition, several peptides were created to specifically block
Gαq, Gαs and Gβδ when measuring phospho-ERK expression in LβT2 cells after
treatment with GnRH. The peptides successfully inhibited phospho-ERK expression
by blocking Gαq and Gαs, but not Gβδ, indicating that signaling is occurring through
Gαq and Gαs. (Liu et al.). The G protein coupled receptor does not activate Gαi/o. This
was examined by blotting for phosphorylated ERK after treating the cells with
pertussis toxin, a chemical known to stimulate Gαi. After treatment with pertussis
toxin, LBetaT2 cells did not show increased levels of phosphorylated ERK compared
to control cells (Liu et al. 2002).

Basic Cellular Communication
Cellular communication is essential in multicellular organisms to coordinate
activities for survival and growth. In order to communicate, cells must interpret
extracellular ligands using receptors that form an intracellular protein cascade, which
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creates the necessary cellular response. Examples of effector protein targets include
gene regulatory proteins, ion channels, components of a metabolic pathway and
cytoskeletal components (Hall and Lefkowitz 2002). By using extracellular signals
for communication, this allows the cell to interact with other cells either nearby or far
away in the organism. Endocrine cells secrete hormones into the blood stream to
signal to other cells. Secreting hormones into the blood stream allows the endocrine
cell to communicate with cells either nearby or very far away in the body.
In order for a cell to receive a signal, it must contain a receptor that recognizes
the signal. Signaling ligands include proteins, small peptides, amino acids, and
nucleotides (Kobilka 2007). Once an extracellular receptor has been activated, the
signal is relayed through the cell by using small molecules and intracellular signaling
proteins. Three of the most common small molecules include cyclic AMP (cAMP),
calcium (Ca+2) and diacylglycerol (DAG). These small signaling molecules help to
relay the signal by binding to and altering the conformation or behavior of proteins
involved in the signaling cascade. The proteins involved in the signaling cascade are
usually intracellular proteins and help to progress or stop the signal by creating
intermediate signaling molecules or changing the conformation of proteins in the
signaling cascade (Brogi et al. 2014). The rate at which the changes are made in the
cell receiving the signal vary depending on the desired outcome of the message
received. Phosphorylation of a protein that is already in the cell occurs quickly while
creation of a new protein or molecule through transcription and translation can take
longer (Alberts, B. Johnson, A. Lewis, J. Raff, M. Roberts, K. Walter 2008).
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G Protein Coupled Receptors
In many cells, messages are relayed from the extracellular space to the
cytoplasm through G-protein coupled receptors (GPCRs). The function of activated
GPCRs is to stimulate or inhibit other proteins in a signal transduction cascade or
regulate an ion channel. The signals that the receptor receives include hormones,
neurotransmitters, and local mediators. G protein coupled receptors are important to
understand in the context of cell signaling because half of all known drugs work
through these receptors (Alberts, B. Johnson, A. Lewis, J. Raff, M. Roberts, K.
Walter 2008). GPCRs are a transmembrane protein that spans through the membrane
seven times and is coupled with a trimeric GTP-binding protein. The GTP-binding
protein is composed of alpha, beta and gamma subunits. In an inactive state, the
alpha subunit has GDP bound to it and the subunits are congregated together. In an
activated state, the alpha subunit dissociates from the trimeric protein and has GTP
bound to it. There are several different isoforms of the alpha subunit, some of which
are stimulatory and some of which are inhibitory (Alberts, B. Johnson, A. Lewis, J.
Raff, M. Roberts, K. Walter 2008).
In LBetaT2 cells, the purpose of signaling through a GPCR is to increase the
amount of cyclic AMP (cAMP) in order to activate protein kinase A (PKA). When
the extracellular portion of the receptor binds a ligand, the receptor undergoes a
conformational change, which allows it to activate the G protein, releasing the alpha
subunit bound to GTP. The stimulated G alpha subunit then activates adenylyl
cyclase (AC), another transmembrane protein. Adenylyl cyclase synthesizes cAMP
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from ATP. The cAMP then binds to PKA in order to activate serine/threonine kinases
(Alberts, B. Johnson, A. Lewis, J. Raff, M. Roberts, K. Walter 2008).
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Figure 1: Signaling cascade leading to the activation of protein kinase A. When the
hormone GnRH, binds to the GnRH receptor, the α subunit of the trimeric GTP
binding protein, becomes activated and dissociates from the βδ subunits. The GTPbound α subunit activates adenylyl cyclase, leading to an increased concentration of
intracellular cAMP. The increased concentration of cAMP activates PKA, which can
then phosphorylate serine and threonine residues on proteins.
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Protein Kinase A
Protein Kinase A, or PKA, is an enzyme that regulates many biological
processes and is associated with disease due to insufficient or inappropriate
phosphorylation (Taylor et al. 2012). Protein Kinase A is a holoenzyme consisting of
two regulatory subunits and two catalytic subunits. The regulatory subunits include
RIα, RIβ, RIIα and RIIβ. The different catalytic subunits include Cα, β, and δ
(Dell’Acqua and Scott 1997). The regulatory and catalytic subunit isoforms allow
for the formation of different isoforms of the holoenzyme, which bind to specific
subcellular locations in the cell. PKA I is primarily found in the cytoplasm where as
PKA II is targeted mainly to subcellular structures (Taskén and Aandahl 2004). The
regulatory subunits each contain two binding sites for cAMP. The two sites on the
regulatory subunit where cAMP can bind are the A site and B site. cAMP binds to
the B site first and then the A site (Taskén and Aandahl 2004). When cAMP is not
bound to the regulatory subunits the enzyme is inactive. Once the cAMP has bound
to the regulatory subunits, then the catalytic subunits are released from the
holoenzyme and are free to phosphorylate on serine or threonine residues on several
different protein substrates (Taskén and Aandahl 2004). Phosphorylation of serine or
threonine residues on specific proteins induce conformational changes that activate or
inhibit cellular processes. In cardiac cells, phosphorylation of L-type calcium
channels by PKA enhances the influx of calcium and depolarization of the cell (Gao
et al. 1997). In gonadotrophs, phosphorylation and enhanced opening of ion channels
could lead to increased calcium influx, depolarization and secretion of hormones
(Dell’Acqua and Scott 1997).
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Figure 2: A model demonstrating the activation of protein kinase A. Protein kinase A
is a holoenzyme consisting of two regulatory (R) subunits and two catalytic (C)
subunits. In an inactive state, cAMP is not bound to the holoenzyme. In an activated
state, the regulatory subunits bind cAMP and the catalytic subunits dissociate from
the regulatory subunits. The catalytic subunits can then phosphorylate threonine and
serine residues on proteins.
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AKAP150
A Kinase Anchoring Proteins (AKAPs) are scaffolding proteins that can bind
both kinases and phosphatases. By localizing kinases and phosphatases in close
proximity to each other allows for greater temporal control in signaling cascades
(Dai, Hall, and Hell 2009). AKAP150 is one of the most studied anchoring proteins
in neuronal and cardiac cells. AKAP150 is expressed in mice and has two orthologs:
AKAP75 in bovine and AKAP79 in humans (Tunquist et al. 2008). The enzymes
most commonly bound to AKAP150 are PKA, calcium/phospholipid-dependent
protein kinase C (PKC) and calcium/calmodulin-dependent protein phosphatase 2B
(PP2B). Each of the enzymes is inhibited when bound to the AKAP and requires
specific second messenger signals to activate the enzymes. The scaffolding complex
is tethered to the interior of the plasma membrane where its binding partner can
respond to second messengers, such as cAMP, calcium, and phospholipids. When
bound to the interior of the plasma membrane, the AKAP 150 family of proteins
controls phosphorylation of ion channels such as AMPA-type glutamate receptors, Ltype calcium channels, aquaporin water channels and M-type potassium channels
(Hoshi, Langeberg, and Scott 2005). By anchoring signaling enzymes in such close
proximity, enzyme regulation can be partially controlled by negative feedback loops.
For example, in addition to phosphorylating substrates, increased PKA activity
activates PP2B, which dephosphorylates the substrate targeted by PKA. In neurons,
AKAP 150 is targeted to post-synaptic densities (Hoshi, Langeberg, and Scott 2005).
The post-synaptic substrates include α-amino-3-hydroxy-5-methyl-4isoxazolepropionic acid (AMPA) receptors, calcium channels and N-Methyl-D	
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aspartic acid (NMDA) receptors in hippocampal synapses (Taskén and Aandahl
2004). In studies involving Human Embryonic Kidney (HEK) cells and native
cardiac myoctes, it was shown that PKA anchored to AKAP150 is necessary for the
phosphorylation of α1C subunits in maintaining an open state of L-type calcium
channels (Gao et al. 1997). In cardiac myocytes, stimulation of L-type calcium
channels by β-adrenergic agonists occurs through a cAMP and PKA-dependent
pathway. Disruption of this pathway by blocking the ability of PKA to bind to
AKAP150 results in reduced calcium channel currents (Gao et al. 1997). In addition
to anchoring PKA, PKC and PP2B, it has been proposed that AKAP150 interacts
with F-actin, phosphatidylinositol-4,5-bisphosphate (PIP2) and cadherin complexes to
anchor the protein in post synaptic densities in neurons. This has been proposed
because the scaffold has been shown to be disrupted by actin polymerization
inhibitors (Dell’Acqua et al. 2006). Due to the unknown nature of what AKAP150 is
binding to, there is not much information about how the protein translocates. The aim
of my thesis is to generate more knowledge about the binding and translocation of
AKAP150 in anterior pituitary cells.
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Figure 3: AKAP150 scaffolding protein model. The three most common enzymes
attached to the AKAP150 scaffolding protein are protein kinase A (PKA), protein
kinase C (PKC) and the calcium/calmodulin-dependent protein phosphatase 2B
(PP2B).
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Intent of Thesis
The goal of this thesis is to study the dynamics of AKAP150 in anterior
pituitary cells. AKAP150 is dynamic protein in the dendritic spines of neuronal cells:
AKAP150 can bind lipids in the cell membrane and actin in the cytoskeleton
(Dell’Acqua et al. 2006). However how the protein translocates and what causes it to
translocate is currently not known. Previous preliminary experiments conducted in
the Angleson lab suggest cortical localization of AKAP150 in endocrine cells
changes with treatment of pharmacological agents. We investigated these changes
using time-lapse imaging, FRAP, FLIP, and immunostaining assays. During this
process, we also demonstrated method development for analyzing quantitative FRAP
data. Using these methods allowed us to learn more about the dynamics of AKAP150
in anterior pituitary cells.
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MATERIALS AND METHODS
Cell Culture
LBetaT2 cells from Pamela Mellon (University of California, San Diego)
were cultured in DMEM media containing 25mM glucose (Cellgro), 1% sodium
pyruvate (Cellgro), 10% fetal bovine serum (Valley Biomedical), 1% of a
penicillin/streptomyocin solution (10,000 IU/mL Penicillin, 10,000 ug/mL
Streptomyocin, Cellgro) and 1.85g sodium bicarbonate (Fisher Scientific). All
ingredients were mixed together and brought up to 500mL with nanopure water. The
media was sterilize filtered with a 0.45µm filter (Cell treat). The cells were
maintained in a humidified incubator with 95% air, 5% CO2 at 37°C. The cells were
split approximately once every seven to ten days.
The 5mM K+ standard external resting solution used during experiments
contained 1mM MgCl2, 10mM HEPES, 5mM CaCl2, 137mM NaCl, 5mM KCl and
10mM D-glucose (pH 7.2). The high potassium solution contained 1mM MgCl2,
10mM HEPES, 5mM CaCl2, 42mM NaCl, 100mM KCl and 10mM D-glucose (pH
7.2).

Plating Cells
Chamber slides were coated with 250µL ECL (EMD Millipore), a cell
adhesion matrix, and incubated at 37°C for 90 minutes. Media was removed from a
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flask containing LβT2 cells and pipetted into a 50mL conical tube. 5ml trypsin
(Corning) was added to flask for three minutes. Each side of the flask was washed
with trypsin and then trypsin was pipetted into the bottom several times to break up
clumps of cells. The cells (and trypsin) were added to the 50mL conical and
centrifuged at 5000rpm for 10 minutes. The supernatant was removed from the cell
pellet and LβT2 media was used to re-suspend the cells. ECL was removed from the
chamber slides and 500µL of cells were added to each chamber. Cells were
incubated at 37°C for 45 minutes.

Plasmid Preps
The AKAP150-GFP plasmid (gift from Mark Dell’Acqua) was isolated using
competent DH5α E. coli cells (Invitrogen). AKAP150-GFP (1µL) plasmid was
added to chilled DH5α cells (100µL) and incubated on ice for 30 minutes. The cells
were heat shocked at 42°C for 50 seconds and then incubated on ice for two minutes.
S.O.C. media (900µL) (Invitrogen) was added to the cells and shaken at 225rpm for 1
hour at 37°C. Transformed cells (10µL) were added to 990µL S.O.C. media
(Invitrogen) and 100µL of that solution was spread on a LB plate containing
kanamycin. The plate was incubated overnight at 37°C. One colony was removed on
a plate with a 200mL pipette tip and added to LB broth (110mL) containing 110µL
kanamycin (50mg/mL). The flask was shaken overnight at 37°C at 300rpm. A
Qiagen maxi plasmid prep kit was used for eluting plasmid from E. coli. The plasmid
(1µg/µL) was diluted with endotoxin-free TE Buffer.
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Transfection of LβT2 Cells
Glass bottom dishes (17mm thick, Wellco) were coated with ECL (300µL)
and put in incubator at 37°C for 1 hour. Opti-Mem or TransfectaGro (1mL) was
warmed to room temperature in a 37°C water bath. Opti-MEM (200µL) was pipetted
into a 1.5mL tube labeled A and into a 1.5mL tube label B. Lipofectamine Reagent
2000 (2µL) was added to tube A. 2µL endotoxin-free AKAP150-GFP plasmid
(1405.2ng/µL) was added to tube B. The reactions incubated at room temperature for
5 minutes. Tube A was added to tube B and the reaction was incubated at room
temperature for 20 minutes. Media was pipetted from the flask and placed in a 50mL
centrifuge tube. Cells were treated with trypsin for three minutes. Each side of the
flask was washed with trypsin and then trypsin was pipetted into the bottom several
times to break up clumps of cells. Cells (and trypsin) were centrifuged at 5000rpm
for 10 minutes and supernatant was removed from the cell pellet. Cells were resuspended in Opti-Mem (100µL). ECL was removed from the glass bottom dishes
and re-suspended cells (25µL) were added to each dish. 100µL from the tube
containing lipofectamine, Opti-MEM and plasmid was added to the cells on the glass
bottom dish. The glass bottom dishes were incubated for three hours in an incubator
at 37°C and containing 95% air and 5% CO2.. LβT2 media (2mL) was added to each
dish and then the incubation at 37°C continued for either 24 or 48 hours.
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Time-lapse Imaging Assay
Perfusion assays were performed using a gravity flow system. One image was
taken every 30 seconds for approximately 10 minutes (20 time points). Perfusion
solutions contained either a standard external solution or the standard resting solution
with a pharmacological agent, added as indicated. The standard resting solution was
5mM K+/10mM glucose. The starting solution for LβT2 cells transfected with
AKAP150-GFP plasmid was the standard external solution. LβT2 cells transfected
with AKAP150-GFP were perfused with the standard resting solution for the first two
minutes of data collection. Immediately after two minutes, the solution was switched
from resting solution to the solution containing a pharmacological agent for 30-60
seconds. After 30-60 seconds, the drug solution was turned off, and the cells were
bathed in the solution containing a pharmacological agent for the remainder of the
imaging. The intensities of the cell surface (‘rim’) were determined by subtracting a
mask created by background signal from a mask created around the rim of a cell.

Permeabilization Assay
Chamber slides (Nalge Nunc International) were coated with ECL (250µL)
and incubated at 37°C for 90 minutes. ECL was removed from slides and 500µL of
LβT2 cells transfected with AKAP150-GFP were added to each chamber. Cells on
chamber slides were incubated at 37°C for 45 minutes. The media was removed, and
the cells were washed three times with phosphate buffered saline solution (PBS). A
4% paraformaldehyde (PFA) solution (Electron Microscopy Solutions) was added to
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the cells for 15 minutes. The PFA solution was removed, and the cells were washed
three times with PBS. To permeabilize cell membranes, a 0.4% Triton X-100 (Fisher
Scientific) solution was added to the cells for 15 minutes. The Triton X-100 solution
was removed, and the cells were washed three times with PBS. The chambers were
removed from the slides and one drop of Vectashield with DAPI (Vector
Laboratories, Inc.) was added to each space containing cells. Glass coverslips (Fisher
Scientific, 18x18-3) were placed on top of the Vectashield and secured in place using
clear nail polish. The intensities of the cell surface (‘rim’) were determined by
subtracting a mask created by background signal from a mask created around the rim
of a cell. For ‘intact cell’ preparation, permeabilization with Triton X-100 was
omitted.

Immunostaining
LβT2 cells were plated on chamber slides. The media was removed and the
cells were washed three times with PBS. A 4% paraformaldehyde (PFA) solution
(Electron Microscopy Solutions) was added to the cells for 15 minutes. The PFA
solution was removed, and the cells were washed three times with PBS. A 0.4%
Triton X-100 solution was added to the cells for 15 minutes. The cells were washed
three times with PBS. A 1:100 primary antibody solution was made with AKAP150
primary antibody (Goat anti-AKAP150, Santa Cruz Biotechnology, Catalog #: SC6445) and blocking solution, normal donkey serum. The cells were incubated with
the primary antibody solution at 37°C for 90 minutes in a humidifying chamber. The
antibody was removed, and the cells were washed three times with PBS. A 1:800
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secondary antibody solution (Alexa 488 anti-goat, Invitrogen) was made by pipetting
secondary antibody into blocking solution with normal donkey serum. The cells were
incubated with the secondary antibody solution at 37°C for 45 minutes in a
humidifying chamber. The cells were washed three times with PBS. The chambers
were removed from the slides, and one drop of Vectashield with DAPI was added to
each space containing cells. Glass coverslips were secured in place using clear nail
polish. In the cell containing drug treatment, the pharmacological agents were added
for five minutes. The pharmacological agents were added after the media was
removed, but before fixing the cells. In order to analyze endogenous AKAP150 and
actin together, Alexa 568 phalloidin was added to the cells after the secondary
antibody, and then the cells were incubated for 20 minutes in a humidifying chamber.

Fluorescence Microscopy
Fluorescence microscopy was performed using an inverted Zeiss Axiovert
S100 TV microscope and recorded with Slidebook version 6.0 digital microscopy
software. Images were acquired with 40x objective (N.A. 1.30). In the Slidebook
software, images were viewed in the focus window with 40x oil objective, exposure
of 1000ms, filter set to Live and the green Live filter was used. Images were acquired
in the capture window with bin factor 1x1 and time lapse.

Confocal Microscopy
Confocal microscopy was performed using a laser scanning Olympus
FluoView FV1000. Fluorescence Recovery After Photobleaching (FRAP) was done
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on single LβT2 cells transfected with AKAP150-GFP using the Fluoview SIM
scanner with Olympus Fluoview Ver 4.1 software. 550 images were acquired for
each video using the 60x objective (N.A. 1.42) and Main Scanner Sync in Fluoview.
The images of the cells were acquired using 5% laser transmission at wavelength 488
and the EGFP filter. The cells were photo bleached using 100% laser transmission at
wavelength 488 and the EGFP filter. The tornado or rectangle tool was used to draw
the region of interest (ROI) on the cell. Brightfield images were taken using 5%
laser transmission at wavelength 488 and TD1 filter. Before imaging either cell type,
media was removed and replaced with 5mM K+ standard external resting solution.
Translocation of AKAP150-GFP was measured by creating recovery curves at
the right, middle and left edges of the ROIs on the rim during photobleaching. When
photobleaching using the baseline parameters, 0.5 microns were measured outside of
the left and right edges of the ROI. 0.25 microns were measured on either side of the
median in the middle of the ROI. When photobleaching using the fast rectangular
and tornado parameters, 0.5 microns were measured outside of the left and right
edges of the ROIs on the rim during photobleaching. 0.25 microns were measured on
either side of the median in the middle of the ROI.
Confocal microscopy was performed on LβT2 single cells immunostained
with anti-AKAP150 and phalloidin. AKAP150 was imaged with the Alexa 488 laser
with 5% transmission. Actin was imaged with the Alexa 568 laser set to 5%
transmission.
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FRAP Analysis
Baseline parameters: A total of 300 frames were acquired at a frame rate of
1.11 seconds per frame for a total time of approximately 5.5 minutes. The
rectangular ROI was bleached for 5 seconds at a speed of 100µs per pixel using 100%
transmission of the 488 laser. The image was acquired using an aspect ratio of
512x512 at a speed of 12.5µs per pixel. The main scanner sync was used to collect
images. 10 frames were taken before photobleaching. Images were acquired for 11
seconds, photobleached for 5 seconds and captured the recovery for 5.2 minutes.
Fast Rectangle parameters: A total of 550 images were acquired at a frame
rate of 0.3 seconds per frame for a total time of approximately 2.75 minutes. The
ROI was photobleached for either one second or 2.5 seconds at a speed of 100µs per
pixel using 100% transmission of the 488 laser. Images were acquired using an
aspect ratio of 128x128 at a speed of 2µs per pixel. The main scanner sync was used
to collect images. 30 frames were taken before photobleaching. A rectangle ROI
(13x49) was used in each experiment and positioned vertically around the cell rim.
Images were acquired for 9 seconds, photobleached for either 0.3 seconds or 0.75
seconds and captured the recovery for approximately 2.5 minutes.
Fast tornado parameters: A total of 550 images were acquired at a frame rate
of 0.3 seconds per frame for a total time of approximately 2.75 seconds. The ROI
was photobleached for either one second or 2.5 seconds at a speed of 100µs per pixel
using 100% transmission of the 488 laser. Images were acquired using an aspect ratio
of 128x128 at a speed of 2µs per pixel. The main scanner sync was used to collect
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images. 30 frames were acquired before photobleaching. A tornado ROI (22x22)
was used in each experiment. Images were acquired for 9 seconds, photobleached for
either 0.3 seconds or 0.75 seconds and captured the recovery for approximately 2.5
minutes.
Quantitative FRAP analysis was provided by Dr. Dinah Loerke and Roopa
Madhu. Watershed analysis was used to define the rim of the cell and MATLAB was
used to generate rim intensity. Rim intensity in the heat maps was calculated by
dividing intensity at a point in time by the pre-bleach intensity. A red color indicates
a value of 1, or maximum intensity. A blue color indicates a value of 0, or zero
intensity.

Statistical Analysis
Slidebook Version 6.0 was used to create masks to analyze rim brightness in
the time-lapse imaging, permeabilization, and immunostaining assays. Kaleidograph
was used to create dot plots and run statistical analyses. Wilcoxon-Rank-Sum tests
were used on non-normal distributions. Student’s t-tests were run on normal
distributions. Statistical significance was considered at p<0.05. Where indicated, data
have been normalized to the third control time point and shown as mean and standard
deviation.
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Drug

Rp-8-CPTcAMPs
6-benzoylcAMP
Pimaric Acid
(PiMA)
Forskolin

Jasplakinolide
Lantrunculin
A

Working
Stock
Function
Concentration Concentration
Selective
inhibitor of
Protein Kinase
A type I and
II.
Competitive
inhibitor of
PKA.
50µM
25mM
Activates
Protein Kinase
A type I and
type II.
20µM
10mM
Activates
Protein Kinase
C
300nm
3.24mM
Activates
adenylyl
cyclase
50µM
20mM
Induces actin
polymerization
and
stabilization
3µM
705mM
Inhibits actin
polymerization 1µM
237mM

Stock
Solvent

DMSO

Water
DMSO
Ethanol

DMSO
Ethanol

Table 1: Pharmacological agents used during experimental procedures. A brief
explanation of the mechanism of action of the pharmacological agents is provided.
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Abbreviation
6-benzoylcAMP

Name
N6-Benzoyladenosine-3',5'-cyclic monophosphate
sodium salt
(3R, 4aR, 5S, 6S, 6aS, 10S, 10aR, 10bS)- 6, 10,
10b- trihydroxy- 3, 4a, 7, 7, 10a- pentamethyl- 1oxo- 3- vinyldodecahydro- 1H- benzo[f] chromenForskolin
5- yl acetate
N-[2-bromo-N-[N-(8-hydroxy-2,4,6-trimethyl-1oxo-4-nonenyl)-L-alanyl]-N-methyl-DJasplakinolide
tryptophyl]-L-3-(4-hydroxyphenyl)
[1R-[1R*, 4Z, 8E, 10Z, 12S*, 15R*, 17R*(R*)]]4-(17-Hydroxy-5,12-dimethyl-3-oxo-2,16dioxabicyclo[13.3.1]nonadeca-4,8,10-trien-17-yl)Lantrunculin A 2-thiazolidinone
Phorbol-12-Myristate-13-Acetate; 12-OTetradecanoylphorbol 13-acetate,
4β,9α,12β,13α,20-Pentahydroxytiglia-1,6-dien-3PMA
one 12-tetradecanoate
Rp-8-cpt8-(4-Chlorophenylthio)adenosine-3′,5′-cyclic
cAMPs
Monophosphorothioate, Rp-isomer sodium salt
Table 2: Abbreviations Nomenclature. An abbreviated nomenclature is provided for
the pharmacological agents used during assays.
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RESULTS
Effects of pharmacological agents on transfected LβT2 cells
The first set of experiments focused on rim intensity changes during confocal
imaging of live imaging in LβT2 cells transfected with AKAP150-GFP. In LβT2
cells, AKAP150 protein localizes to the cell rim. The purpose of these experiments
was to determine if AKAP150-GFP is mobile upon the introduction of specific
pharmacological agents in solution.

Time-lapse Imaging of Transfected LβT2 Cells
The time-lapse imaging assays were performed by collecting one image every
30 seconds for approximately 10 minutes (20 time points). When collecting the livecell data from time-lapse imaging, the change of rim brightness was plotted in a graph
displaying intensity over time(s). One image was taken every 30 seconds to minimize
unintended photobleaching. The experiment began with cells in the standard resting
solution for two minutes (four control time points) and then switched to a resting
solution with a pharmacological agent. The control cell maintained constant rim
fluorescence intensity, verifying that unintended photobleaching was not causing a
decrease in rim intensity. In Figures 4B-4D, where the pharmacological agents
activated or inhibited PKA, the cells treated with rp8-cpt-cAMPs and forskolin
showed a trend in decreasing fluorescence intensity, but the cell treated with 6	
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benzoyl-cAMP did not. In Figures 4E-4F, where the pharmacological agents
activated PKC and caused an increase in Ca+2, the cells treated with both PMA and
100mM K+ showed a trend of decreasing fluorescence. Lastly, in Figures 4G-4H,
where the pharmacological agents stabilized or inhibited actin polymerization, the
cells treated with jasplakinolide and lantrunculin A showed a minimal decrease in
fluorescence intensity. The results of experiments with PMA were promising because
they indicated the translocation of AKAP150-GFP. It is possible that we did not
observe a significant decrease in fluorescence intensity in the cells treated with the
pharmacological agents other than PMA because AKAP150-GFP was translocating
laterally. The trend in decreased fluorescence suggested possible translocation from
the rim to the cytosol. Lateral translocation only of AKAP150-GFP would not cause
a significant decrease in fluorescence intensity. We decided we needed a more
sensitive method to study the translocation of AKAP150-GFP in anterior pituitary
cells. The more sensitive method we used was FRAP.
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Figure 4: Mobility of AKAP150-GFP in time-lapse imaging assays. In each of the
assays, LβT2 cells transfected with AKAP150-GFP were imaged once every 30
seconds for 10 minutes (20 time points). For the first two minutes (four time points),
cells were bathed in standard resting solution and then switched to a resting solution
containing a pharmacological agent. (A) Control (B) Rp-8-cpt-cAMPs (C) 6benzoyl-cAMP (D) Forskolin (E) PMA (F) 100mM K+ (G) Jasplakinolide (H)
Lantrunculin A
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Fluorescence Recovery After Photobleaching (FRAP) on LβT2 Cells
Transfected with AKAP150-GFP
To focus further on the translocation of AKAP150 in LβT2 cells, we tested
the mobility of the scaffolding protein by measuring recovery of AKAP150-GFP after
photobleaching. FRAP would provide a more sensitive method to test the mobility of
AKAP150-GFP. It is predicted the recovery of AKAP150-GFP could translocate
from the rim, cytosol or both. It is unknown how the scaffolding protein moves
within the cell, for example diffusing freely or binding to a structure, such as actin.
Previous in vitro studies have suggested that AKAP150 attaches directly to both the
actin cytoskeleton and lipids in the membrane (Dell’Acqua et al. 2006).

Fluorescence Recovery After Photobleaching in LβT2 Cells
In order to study AKAP150-GFP mobility using a more sensitive method, we
analyzed quantitative FRAP data. Baseline parameters were established for the
FRAP imaging. The ROI appears to almost be completely photobleached at frame
13, which is about 3.3 seconds into the 5-second photobleach. Recovery is not
apparent in the photobleached area at 5.5 seconds post-photobleach. A very dim rim
is visible at 27.5 seconds post-photobleach. The rim is visible at both 159.5 and
324.5 seconds post-photobleach. Although the fluorescence of the rim recovers
following photobleach, it did not appear as bright as the rim pre-photobleach. This
FRAP data indicate that AKAP150-GFP in LβT2 cells is mobile.
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Figure 5: Fluorescence Recovery After Photobleaching (FRAP) of an LβT2 cell
transfected with AKAP150-GFP. Cells were imaged on a laser scanning confocal
microscope using the preliminary parameters.
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Hypothetical Schematics of Recovery from FRAP
In order to visualize the origin of the recovered AKAP150-GFP in the cell, we
created a post-photobleaching recovery model (Figure 7). Cell A shows the recovery
of AKAP150-GFP expression originating from a cytosolic pool of AKAP150 only.
Recovery from the cytosol would be considered rapid because every area along the
rim that was photobleached has access to the soluble, cytosolic pool of AKAP150GFP. Cell B shows recovery due to the lateral movement of AKAP150-GFP at the
rim only. Recovery along the rim is expected to take longer because the protein must
move a greater distance (laterally from the outside of the bleached area to the middle
of the ROI). The green arrows above cell B show Fluorescence Loss in
Photobleaching (FLIP) from the region outside of the ROI. We expect this to occur
as AKAP150-GFP translocates to the inside of the ROI to aid in recovery. Cell C
shows recovery of expression due to movement of AKAP150-GFP from both the rim
and cytosol. Similar to Cell B, a combination of cytosolic and lateral translocation
would also show FLIP in the region outside of the ROI. The difference in speeds
from a combination of cytosolic and rim recoveries is dependent on the rate-limiting
constant, koff. Koff is the time it takes for a photobleached protein to detach from a
subcellular structure before being replaced by a fluorescent protein from the cystolic
pool or rim. Since the cytosolic pool of protein is soluble, it is predicted that recovery
will occur quicker than the lateral movement of recovery along the rim. If the
constants between the two recoveries are similar, it could be difficult to separate
cytosolic from rim recovery. It is conceivable that a faster acquisition speed could be
used to identify different recoveries.
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Figure 6: Model depicting lateral and cytosolic recovery of AKAP150-GFP after
photobleaching. Cell A depicts cytosolic recovery of AKAP150-GFP in ROI postphotobleaching. The recovery in cell A comes from the mobile fraction of
AKAP150-GFP protein found in the cytosol of LβT2 cells. Cell B depicts rim
recovery of AKAP150-GFP in ROI post-photobleaching. The recovery in cell B
comes from the mobile fraction of AKAP150-GFP protein found along the rim of
LβT2 cells. Cell C depicts simultaneous cytosolic and rim recovery of AKAP150GFP in ROI post-photobleaching. The recovery in cell C comes from the mobile
fractions of AKAP150-GFP found in both the cytosol and rim of LβT2 cells.
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Recovery Curves from LβT2 Cell after FRAP
The FRAP experiment verified the mobility of AKAP150-GFP in LβT2 cells;
however, the mechanism of recovery was not understood. Thus, further analysis of
the FRAP data was completed. The recovery curves in Figures 8A-8C show the
recovery of fluorescence within inside of the ROI. The y-axes of the graphs represent
fluorescence intensity of the AKAP150-GFP protein and the x-axes represent time.
Figure 8A displays the recovery at the left edge of the ROI. Figure 8B displays the
recovery in the middle of the ROI. Figure 8C displays the recovery of the right edge
of the ROI. By comparing the recovery curves along the edges of the ROI to the
recovery curve at the middle of the ROI, the fluorescence at the middle of the ROI
takes the longest to recover. This could be due to the fact that the middle of the ROI
decreases in fluorescence more than the edges. This could also result from lateral
recovery of AKAP150-GFP. Figure 8D shows the intensity along the entire rim of
the cell. The shape of the decrease of intensity in Figure 8D is rectangular. This is
the shape that we strive to achieve each time during photobleaching because it
displays consistent bleaching along the cell rim. These results demonstrate that
AKAP150-GFP translocates during recovery.
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Figure 7: Recovery of AKAP150-GFP inside of the ROI using preliminary
parameters during FRAP. Recovery curves were generated from the cell shown in
Figure 6. The recovery curves display a change in intensity over time. (A) Change in
intensity at the left edge of the ROI. (B) Change in intensity in the middle of the
ROI. (C) Change in intensity at the right edge of the ROI. (D) Graph showing
intensity along the entire rim of the cell.
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In addition to measuring the recovery of the area inside of ROI, we examined
recovery of the rim outside of the ROI. A loss in fluorescence outside of the ROI
would provide the most convincing evidence that AKAP150-GFP is mobile. Figure
9A measures the change in fluorescence intensity outside of the left edge of the ROI.
Figure 9B measures the change in fluorescence intensity outside of the right edge of
the ROI. The gray line in Figures 9A and 9B mark when photobleaching occurred.
Fluorescence Loss in Photobleaching (FLIP) occurs on both edges of the ROI. This
supports the hypothesis that AKAP150-GFP translocates laterally from the outside of
the ROI to the inside of the ROI during recovery after photobleaching.
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Figure 8: Fluorescence Loss in Photobleaching (FLIP) in the rim outside of the ROI.
Preliminary parameters were used for imaging during FRAP. An area of 0.5 microns
was measured on each side along the rim outside of the ROI. Recovery curves were
generated from the cell shown in Figure 6. The recovery curves display the change in
intensity over time. (A) Change in intensity at the left edge outside of the ROI. (B)
Change in intensity at the right edge outside the ROI.
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Simulation Heat Maps of Recovery from FRAP
Simulation heat maps were created to depict changes in fluorescence intensity
along the cell rim over time (Figure 10). The simulated data in the heat maps
demonstrate predicted data. The heat maps show relative intensity of the cell rim
over time. The color red depicts a high intensity, or maximum fluorescence, with a
value of 1. The color blue depicts a low intensity, or zero fluorescence, with a value
of 0. The x-axis of the heat map represents the cell membrane. The y-axis of the heat
map represents time. The black bars on the heat map show the boundaries of the
ROI. The heat map in Figure 10A shows the fluorescence recovery if AKAP150GFP recovered only from the cytosol. The cytosolic recovery appears to have a flat
base since the rate recovery should be the same along the entire distance of the rim.
The heat map in Figure 10B is the predicted recovery if AKAP150-GFP recovered
laterally along the rim. The shape of the signal is more ovoid and demonstrates that
the middle of the bleached region is the last to recover. The heat map in Figure 10C
is the hypothetical recovery if AKAP150-GFP were to recover from both the cytosol
and cell rim. A combination of lateral and cytosolic recovery creates wing-like
shapes during FLIP outside of the ROI.
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Figure 9: Simulation heat maps of AKAP150-GFP recovery after FRAP. The x-axis
displays distance along the membrane. The y-axis displays time. The color red
indicates a high intensity, or the maximum fluorescence. The color blue indicates a
low intensity, or zero fluorescence. The black bars represent the boundary of
photobleaching. The heat map demonstrates (A) Recovery from cytosol. (B) Lateral
recovery from the rim.
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Heat Map of LβT2 Cell Recovery after FRAP
A heat map depicting the recovery of AKAP150-GFP from FRAP data was
plotted to determine if recovery was occurring from the cytosol, rim or both (Figure
11). The x-axis represents the distance along the rim of the cell, and the y-axis
represents time. The two arrows at the top of the heat map indicate the boundaries of
the ROI. The red color at the top of the membrane depicts the first 11 seconds of the
imaging before bleaching occurred. The deep blue color after the red portion depicts
the 5-second bleach. The rest of the image after the 5-second bleach shows the
recovery of the cell 314 seconds (5.2 minutes). Immediately after the cell was
bleached for 5 seconds, the ROI decreases in fluorescence intensity and remains at a
decreased intensity over time. The fluorescence loss in photobleaching outside of the
ROI indicates that AKAP150-GFP translocates from outside of the ROI to inside of
the ROI. This result further supports what we observed Figure 8 and Figure 9.
Together, these results strongly suggest that AKAP150-GFP translocates laterally
after photobleaching.
While analyzing the heat maps, we noticed spots along the rim (relatively
distant from the ROI) that changed in fluorescence over time. The spots showed
dynamic changes in fluorescence on a much slower time scale than FRAP. We
thought that the spots could be the result of over expression of the AKAP150-GFP
plasmid. Due to this, we focused on improving temporal resolution rather than
investigating the nature of the spots.
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Figure 10: Heat map displaying AKAP150-GFP recovery using preliminary
parameters during FRAP. The preliminary parameters were used for imaging during
FRAP. The x-axis is distance along the membrane. The y-axis is time. The black
arrows indicate the boundaries of the ROI. Red is fluorescent. Blue is nonfluorescent.
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Method Development
Rapid Photobleaching with Rectangular Regions of Interest
Since concluding that AKAP150-GFP is mobile in LβT2 cells, we wanted to
maximize the capabilities of the confocal microscope to ascertain if we could
differentiate between cytosolic and rim recoveries. We determined that a faster
acquisition speed and decreased photobleach duration were needed in order to detect
differences between lateral and cytosolic recovery during the fast phases of recovery.
Since we predicted that recovery from the cytosol is rapid due to availability of
soluble protein, it was important to bleach for as little time as possible so as to not
bleach the proteins potentially aiding in recovery. In addition to increasing
acquisition speed, we found that a decreased aspect ratio binned pixels in a smaller
area, allowing for a quicker frame rate. Using these new parameters, we analyzed
recovery with the fast rectangle parameters. We continued to use a rectangular ROI
because it did not bleach as far into the cytosol as a circular ROI.
Two different photobleach time spans were used to examine recovery of
AKAP150-GFP during FRAP with the fast rectangle parameters. One photobleach
time span lasted 1 second. The other photobleach time span lasted 2.5 seconds. The
ROI drawn around the cell in the different time spans was the same size and
positioned vertically around the rim of one cell, as shown in Figure 6. When
comparing bleach time spans at 1 second, it was noticed that there was a lot of
variability in the extent of ROI was photobleaching (Figures 12A and 12B). The
same trend was noticed when comparing the 2.5 second bleach time spans (Figures
12C and 12D). In Figure 12B, photobleaching for one second decreased
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fluorescence intensity to near zero along the entire length of the ROI. The shape of
the region photobleached appears as a rectangle. This is different from Figure 12A,
where photobleaching with the same settings neither decreased fluorescence intensity
to the same degree nor photobleached in the shape of a rectangle. The same trend of
variation in shape and decreased fluorescence intensity was observed in Figures 12C
and 12D, where the cells were photobleached for 2.5 seconds.
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Figure 11: Comparison of ROIs when using fast rectangle parameters during FRAP.
(A) Cell photobleached for one second. (B) Cell photobleached for one second. (C)
Cell photobleached for 2.5 seconds. (D) Cell photobleached for 2.5 seconds.
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In the process of method development, we treated cells with Rp-8-cpt-cAMPs
to potentially determine a biological effect of inhibiting protein kinase A. Figure 13
measures recovery of a control cell photobleached for one second. Figure 14
measures recovery of a cell treated with rp-8-cpt-cAMPs and photobleached for one
second. The fast rectangle parameters were used when imaging these cells. When
comparing the recovery of the control cell to the drug treated cell after one second of
photobleaching, it is difficult to perceive a difference. The recovery curves at the
edges of the ROI in the control cell recovered instantly (Figures 13A and 13C)
whereas the recovery curves at the edges of ROI in the rp-8-cpt-cAMPs treated cell
took more time to recovery (Figures 14A and 14C). Recovery in the middle of the
ROI in control cell (Figure 13B) was quicker than in the cell treated with rp-8-cptcAMPs (Figure 14B). The photobleaching decreased fluorescence shape of a
rectangle in the cell treated with rp-8-cpt-cAMPs (Figure 14D), but not in the control
cell (Figure 13D). This could account for the difference in appearance of the
recovery curves. The heat maps also show the difference of the photobleaching
between the control (Figure 13E) and cell treated with rp-8-cpt-cAMPs (Figure 14E).
The difference in photobleaching could account for the differences in recovery. It is
not yet possible to determine if the difference in recovery was from treatment with rp8cpt-cAMPs. Due to the variability of photobleaching within the ROIs of the control
and drug-treated cells, it was difficult to interpret the biological significance of the
results.
Considering that the results with a one second photobleach were difficult to
interpret, we decided to compromise speed for greater bleach efficacy. Figure 15
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measures recovery of a control cell photobleached for 2.5 seconds. Figure 16
measures recovery of a cell treated with rp-8-cpt-cAMPs and photobleached for 2.5
seconds. Both cells were imaged using the fast rectangle parameters during FRAP.
The recovery of the fluorescence of the cell treated with rp-8-cpt-cAMPs (Figure 16)
was different from that of the control cell (Figure 15). The recovery curves for the
outside edges of the ROI in the control cell recover quicker and to pre-bleach
fluorescence intensity (Figures 15A and 15C). The recovery curves for the outside
edges of the ROI in the cell treated with rp-8-cpt-cAMPs show a slower increase in
fluorescence and do not appear to recover to the pre-bleach fluorescence intensity
(Figures 16A and 16C). These same trends were observed in the heat maps (Figures
15E and 16E). In both of the heat maps, a small amount of FLIP is observed outside
of the ROI, indicating lateral recovery. Similar to the cells photobleached for one
second using a rectangular ROI, a lot of variability occurred in the photobleaching
with a 2.5-second time span. The decrease in fluorescence intensity during
photobleaching is not as uniform in the control cell (Figure 15D) as the cell treated
with rp-8-cpt-cAMPs (Figure 16D). Due to this variability, we could not come to any
biological conclusions about the effects of treatment with rp-8-cpt-cAMPs. We did
conclude that photobleaching for 2.5 seconds produces a consistent decrease in
fluorescence intensity in the ROI.
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Figure 12: Recovery of AKAP150-GFP after photobleaching for one second using
the fast rectangle parameters. (A) Change in intensity at the left edge of the ROI. (B)
Change in intensity in the middle of the ROI. (C) Change in intensity at the right
edge of the ROI. (D) Fluorescence intensity along the entire rim of the cell. (E) Heat
map after FRAP. The black bars show the boundaries of the ROI.
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Figure 13: Recovery of AKAP150-GFP treated with rp-8-cpt-cAMPs after
photobleaching for one second using the fast rectangle parameters. (A) Change in
intensity at the left edge of the ROI. (B) Change in intensity in the middle of the
ROI. (C) Change in intensity at the right edge of the ROI. (D) Fluorescence intensity
along the entire rim of the cell. (E) Heat map after FRAP. The black bars show the
boundaries of the ROI.
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Figure 14: Recovery of AKAP150-GFP after photobleaching for 2.5 seconds using
the fast rectangle parameters. (A) Change in intensity at the left edge of the ROI. (B)
Change in intensity in the middle of the ROI. (C) Change in intensity at the right
edge of the ROI. (D) Fluorescence intensity along the entire rim of the cell. (E) Heat
map after FRAP. The black bars show the boundaries of the ROI.
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Figure 15: Recovery of AKAP150-GFP treated with rp-8-cpt-cAMPs after
photobleaching for 2.5 seconds using the fast rectangle parameters. (A) Change in
intensity at the left edge of the ROI. (B) Change in intensity in the middle of the
ROI. (C) Change in intensity at the right edge of the ROI. (D) Fluorescence intensity
along the entire rim of the cell. (E) Heat map after FRAP. The black bars show the
boundaries of the ROI.
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Rapid Photobleaching with Tornado Region of Interest
Since using a rectangular region of interest did not provide homogenous
photobleaching within the ROI, we photobleached more of the cytosol in order to
achieve more consistent results. The tool we used to provide a more consistent
photobleach was the tornado ROI; the settings used during these experiments are
referred to as fast tornado parameters. Similar to the data collected when using the
rectangular ROI, cells were photobleached for either one second or 2.5 seconds. The
shape of the tornado ROI was the same size in each of the movies and the location of
the ROI on each of the cell rims was similar. Figure 17 measures recovery of a
control cell after one second of photobleaching. Figure 18 measures recovery of a
cell treated with rp-8-cpt-cAMPs after one second of photobleaching. The decrease
in fluorescence intensity due to photobleaching is less in the control cell (Figure 17D)
than in the cell treated with rp-8-cpt-cAMPs. The recovery curves of the edges and
middle of the ROI in the control cell look very different from the cell treated with rp8-cpt-cAMPs. In the recovery curve for the left edge of the ROI, recovery occurs
very quickly and then decreases again. The same trend is observed in recoveries at
the right edge and at the middle of the ROI (Figure 17B and 17C). The recovery
curve of the left edge of the ROI in the cell treated with rp-8-cpt-cAMPs does not
appear to decrease in fluorescence intensity, indicating that it was never
photobleached or recovered as it was photobleached (Figure 18A). The recovery
curves of the right edge and middle of the ROI show the same trends (Figure 18C and
18B). The recovery curve showing the middle of the ROI in the cell treated with rp8-cpt-cAMPs decreases in fluorescence intensity for a longer time than the right edge
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of the ROI, but then appears to recover quicker (Figure 18D). However, in the heat
map of the control cell (Figure 17E), FLIP outside of the ROI is not observed, making
it difficult to come to a conclusion about the translocation of AKAP150-GFP. In the
heat map from the cell treated with rp-8-cpt-cAMPs, (Figure 18E), FLIP does occur
outside of the ROI, indicating lateral movement of AKAP150-GFP. Similar to the
data collected with the fast rectangle parameters, we could not come to any biological
conclusions about the recovery of AKAP150-GFP due to the inconsistency of
photobleaching. Thus, we decided to compromise speed for greater photobleach
efficacy. Figure 19 shows recovery of a control cell photobleached for 2.5 seconds.
Figure 20 shows recovery of a cell treated with rp-8-cpt-cAMPs and photobleached
for 2.5 seconds. When comparing the recoveries, it is difficult to determine if there is
a biological difference with treatment of rp-8-cpt-cAMPs. The difference could be
from inconsistent photobleaching. The decrease of fluorescence intensity during
photobleaching in the cell treated with rp-8-cpt-cAMPs (Figure 20D) is greater than
in the control cell (Figure 19D). Recovery is slowest in the middle of the ROI in the
control cells, indicating lateral translocation of AKAP150-GFP (Figure 19B).
Recovery in the cell treated with rp-8-cpt-cAMPs is slower than in the control cell.
Recovery in the middle of this ROI was the slowest and never recovered to pre-bleach
fluorescence intensity (Figure 20C). The differences in fluorescence intensity during
photobleaching were also observed in the heat maps. In the cell treated with rp-8-cptcAMPs, the ROI is blue, indicating complete photobleaching of the ROI. This was
not observed in the control cell. Due to the variability of photobleaching, we are not
yet able to come to a conclusion about the recovery of AKAP150-GFP in cells treated
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with rp-8-cpt-cAMPs. Similar to the rectangular ROI, photobleaching for 2.5 seconds
with the tornado ROI produced promising results for future experiments.
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Figure 16: Recovery of AKAP150-GFP after photobleaching for one second using the
fast tornado parameters. (A) Change in intensity at the left edge of the ROI. (B)
Changes in intensity in the middle of the ROI. (C) Changes in intensity at the right
edge of the ROI. (D) Fluorescence intensity along the entire rim of the cell. (E) Heat
map after FRAP. The black bars show the boundaries of the ROI.
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Figure 17: Recovery of AKAP150-GFP treated with rp-8-cpt-cAMPs after
photobleaching for one second with the fast tornado parameters. (A) Changes in
intensity at the left edge of the ROI. (B) Changes in intensity in the middle of the
ROI. (C) Changes intensity at the right edge of the ROI. (D) Changes intensity along
the entire rim of the cell. (E) Heat map after FRAP. The black bars show the
boundaries of the ROI.
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Figure 18: Recovery of AKAP150-GFP after photobleaching for 2.5 seconds using
the fast tornado parameters. (A) Changes in intensity at the left edge of the ROI. (B)
Changes in intensity in the middle of the ROI. (C) Changes in intensity at the right
edge of the ROI. (D) Fluorescence intensity along the entire rim of the cell. (E) Heat
map after FRAP. The black bars show the boundaries of the ROI.
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Figure 19: Recovery of AKAP150-GFP after treated with rp-8-cpt-cAMPs and
photobleaching for 2.5 seconds using the fast tornado parameters. (A) Changes in
intensity at the left edge of the ROI. (B) Changes in intensity in the middle of the
ROI. (C) Changes in intensity at the right edge of the ROI. (D) Fluorescence
intensity along the entire rim of the cell. (E) Heat map after FRAP. The black bars
show the boundaries of the ROI.

	
  

58

Since the extent of photobleaching showed substantial variability, we
compared the intensity profiles of the tornado ROIs (Figure 21) to verify that the
decrease in fluorescence intensity produced by each ROI was different. In theory, the
decrease in fluorescence intensity from photobleaching for 2.5 seconds should be
greater than photobleaching for one second. The size of each ROI in Figure 21 is the
same with the exception of the ROI represented by the red profile. This ROI
represented by the red profile was slightly smaller. The decrease in fluorescence
intensity was not uniform when photobleaching for either one second or 2.5 seconds.
Under the same conditions, photobleaching for one second or 2.5 seconds yields the
same decrease in fluorescence intensity. Photobleaching for the same amount of time
yields different decreases in fluorescence intensity. The two profiles with the largest
decrease fluorescence intensity were photobleached for different times; one was
photobleached for one second and the other photobleached for the 2.5 seconds. The
shape created by the decrease in fluorescence intensity shown with the ROIs
represented by the red and black profiles was what we aimed to achieve during each
photobleach. We are now aware we can achieve this shape, but are unsure of how to
consistently achieve it.
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Figure 20: Comparison of intensity profiles during photobleaching using the fast
tornado parameters. The size of the ROI was the same in each profile with the
exception of the ROI designated by the red line, which used a slightly smaller ROI.
The profiles labeled as Control are control cells. Profiles labeled as Drug are cells
treated with rp-8-cpt-cAMPs. Control 9 was photobleached for one second. Control
10, was photobleached for 2.5 seconds. Drug 10 was photobleached for 2.5 seconds.
Drug 11 was photobleached for one second. Drug 12 was photobleached for 2.5
seconds.
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Immunostaining of Endogenous AKAP150 and Actin
To determine if the spots were a result of over expression of AKAP150-GFP,
control LβT2 cells were immunostained for endogenous AKAP150 and actin (Figure
23). Endogenous AKAP150 staining revealed a rim composed of spots, verifying that
the spots are not a result of over expression. Cells immunostained with endogenous
AKAP150 were treated with rp-8-cpt-cAMPs or 6-benzoyl-cAMP. When comparing
rim brightness in the control, rp-8-cpt-cAMPs-treated and 6-benzoyl-cAMP-treated
cells, it is difficult to identify a differnce. When comparing the rim brightness of
actin in the control, rp-8-cpt-cAMPs-treated and 6-benzoyl-cAMP-treated cells, the
actin treated with rp-8-cpt-cAMPs appears brightest. We did not make any intensity
measurements on the spots. The appearance of increased brightness was determined
by how they appeared to us. There is a similarity between the bright spots on the
cells immunostained for AKAP150 and actin, suggesting that AKAP150 and actin are
localized in the same areas.
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Figure 21: Immunostaining of endogenous AKAP150 and actin. Cells were fixed,
permeabilized and immunostained for AKAP150 and actin. Cells were imaged using
a laser scanning confocal microscope. AKAP150 was imaged with the Alexa 488
laser with 5% transmission. Actin was imaged with the Alexa 568 laser set to 5%
transmission.
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To analyze whether there was a statistically significant difference in
fluorescence intensity between control cells and cells treated with rp-8-cpt-cAMPs
and 6-benzoyl-cAMP, a students’s t-test was used. In addition to the t-test, dot plot
graphs were created to demonstrate the normal distribution and median of
fluorescence intensity (Figure 24). There is a significant difference in AKAP150
fluorescence intensity between the control cells and the cells treated with rp-8-cptcAMPs. There is also a significant difference in AKAP150 fluorescence intensity
between the control cells and the cells treated with 6-benzoyl-cAMP. In both results,
AKAP150 decreased fluorescence intensity after treatment with the pharmacological
agent. It was not the same case with actin. There is a significant difference in actin
fluorescence intensity between control cells and cells treated with 6-benzoyl-cAMP,
but not in cells treated with rp-8-cpt-cAMPs.
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Figure 22: Comparison endogenous AKAP150 rim brightness in cells treated with rp8-cpt-cAMPs or 6-benzoyl-cAMP. Cells were imaged on a scanning laser confocal
microscope. Control cells N= 24, Cells treated with rp-8-cpt-cAMPs N=10, Cells
treated with 6-benzoyl-cAMP N=18. Cells were imaged using the same settings as
the endogenous staining. Statistics: Student t-test between control cells and cells
treated with rp-8-cpt-cAMPs, p=0.025. Student t-test between control cells and cells
treated with 6-benzoyl-cAMP, p=0.0007.
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Figure 23: Comparison of actin rim brightness in cells treated with rp-8-cpt-cAMPs
or 6-benzoyl-cAMP. Cells were imaged on a scanning laser confocal microscope.
Cells were analyzing by drawing masks on the fluorescent rims and subtracting
background. Control cells N= 24, Cells treated with rp-8-cpt-cAMPs=10, Cells
treated with 6-benzoyl-cAMP N=18. Cells were imaged using the same settings as
the endogenous staining. Statistics: Student t-test between control cells and cells
treated with rp-8-cpt-cAMPs, p=0.464. Student t-test between control cells and cells
treated with 6-benzoyl-cAMP, p=0.005.
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Permeabilization Assay in Transfected LβT2 Cells
Seeing that the rims of the LβT2 cells stained for endogenous AKAP150 had
a more puncta appearance than the cells transfected with AKAP150-GFP, we
wondered if permeabilization was causing AKAP150 to disappear. If AKAP150 was
binding to lipids in the cell membrane, it is possible that the holes created by Triton
X-100 during permeabilization were causing AKAP150 to leave the rim. Cells were
permeabilized after fixation, but before the addition of DAPI. Images of cells
permeabilized or non-permeabilized were compared to demonstrate differences in rim
appearance (Figure 25). The cells in Figure 25A had intact rims and the cells in
Figure 25B were permeabilized. There was a difference in the appearance of the rim
when comparing the intact to the permeabilized cell rim. The rim of the cell
permeabilized exhibits a slight increase in puncta appearance, but it does not look
similar to endogenous rim staining of AKAP150. The changes in fluorescence
intensity were compared using a dot plot illustrating the distribution and median of
the data (Figure 26). While there was a significant statistical difference in rim
brightness, the non-normal distribution is mostly likely caused by transient nature of
transfection. Each cell does not over-express the same amount of AKAP150-GFP
during a transfection, leading to a non-normal distribution of fluorescence intensity.
Based on these results, we concluded that the AKAP150 endogenous staining pattern
in LβT2 cells was substantive.
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Figure 24: Comparison of rims from intact and permeabilized LβT2 cells transfected
with AKAP150-GFP. Non-permeabilized (intact) cells were fixed after transfection
with AKAP150-GFP. Permeabilized cells treated with Triton X-100 before fixation.
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Figure 25: Comparison of rim brightness from intact and permeabilized LβT2 cells
transfected with AKAP150-GFP. Non-permeabilized (intact) cells were fixed after
transfection with AKAP150-GFP. Permeabilized cells treated with Triton X-100
before fixation. Non-permeabilized cells: N=65, median intensity: 58.472.
Permeabilized cells: N=46, median intensity: 42.987. Statistics: Wilcoxon-Rank-Sum
Test, p=0.006.
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DISCUSSION
Major Conclusions
From our experiments we conclude that AKAP150-GFP is mobile in LβT2
cells and it appears to move laterally along the rim. The mobility of AKAP150-GFP
was demonstrated in the time-lapse (Figure 4) and FRAP (Figure 11) assays. The
decrease in fluorescence intensity in most observed of the cells treated with
pharmacological agents in the time lapse assays suggests that AKAP150-GFP was
mobile. As a more sensitive system in which to examine the translocation of
AKAP150-GFP, we analyzed the mobility of AKAP150-GFP using FRAP. Heat
maps created from the FRAP data provided evidence that AKAP150-GFP moved
laterally along the cell rim. Not only did the heat maps show recovery within the
ROI, the maps demonstrate FLIP outside of the ROI. The fluorescence loss in
photobleaching outside of the ROI shows that AKAP150-GFP translocates laterally
from outside of the ROI to inside of the ROI during recovery (Figure 9). Results
supporting lateral mobility were also observed in the recovery curves. In almost all
of the recovery curves, the middle of the ROI recovered slower than the edges of the
ROI.
The recovery of AKAP150-GFP could be affected by the higher expression of
endogenous AKAP150 and actin within the spots observed in cells immunostained
for AKAP150 and actin (Figure 23). The biological nature of the spots is not yet
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known. It is possible that the spots provide a barrier or sink to lateral and cytosolic
movement during recovery. It is possible that AKAP150 must first bind to the spots
before continuing translocation during recovery. When comparing the profile
fluorescence intensities of AKAP150 to actin, it appears to be similar. This suggests
that AKAP150 could be bound (directly or indirectly) to actin in LβT2 cells. The
significant decrease in AKAP150 fluorescence intensity in cells treated with rp-8-cptcAMPs or 6-benzoyl-cAMP suggests a change in localization of the scaffolding
protein upon the activation or inhibition of PKA (Figure 24). The significant
decrease in actin fluorescence intensity in cells treated with 6-benzoyl-cAMP could
be occurring due to actin remodeling. In pancreatic β cells, filamentous actin is
remodeled before secretion of insulin (Kalwat and Thurmond 2013).
When contemplating how mobility of AKAP150 impacts signaling in LβT2
cells, it is feasible that it adds another level of negative feedback. By removing PKA
from its target protein, AKAP150 inhibits the possibility of erroneous, activating
phosphorylation. A different way that the mobility of AKAP150 impacts signaling is
through signaling cascades. It is imaginable that the scaffolding protein is involved
with multiple different signaling cascades. Translocating to different areas in the cell
would allow AKAP150 to participate in several pathways. In specific areas of the
cell, AKAP150 could bind different enzymes. This would allow AKAP150 to create
different changes in the cell based on localization.
While the scanning laser confocal microscope provided conclusive results
using the preliminary parameters, we realized increasing temporal resolution is more
challenging than anticipated. In order to minimize photobleaching in the cytosol, the
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fast rectangular parameters were used during FRAP (Figure13- Figure 16). We
predicted this would allow us to identify a difference between cytosolic and lateral
recovery. After several FRAP experiments, we realized that the ROI was not
uniformly photobleached (Figure 12). Increasing the amount of time photobleached
from one second to 2.5 seconds did improve in decreasing fluorescence intensity, but
not consistency. Deciding to forgo cytosolic photobleaching in favor of a more
consistent decrease in fluorescence intensity, the fast tornado parameters were used
during FRAP (Figure 17- Figure 20). Similar to the fast rectangular parameters
results, there was inconsistency in the photobleaching when using a tornado ROI.
Increasing photobleaching from one second to 2.5 second did improve in decrease
fluorescence intensity, but not consistency. These results were substantiated when
viewing the tornado ROI intensity profiles (Figure 21). The scanning laser confocal
microscope does not provide consistent photobleaching when using the fast rectangle
parameters or the fast tornado parameters. Due to inconsistency during
photobleaching, the average shape of the ROI is different from what would be ideal
(Figure 22). The ideal shape during photobleaching is rectangular, as shown in the
red and black intensity profiles in Figure 21. In analyzing data collected from the fast
rectangle parameters and the fast tornado parameters, we came to the conclusion that
out of the several FRAP movies collected, only a few were useful. The best way to
collect data from the fast rectangle or tornado parameters might be to take several
FRAP videos and only use the results have a rectangular shaped intensity profile. It is
possible that the scanning laser confocal microscope can only produce an adequate
decrease in fluorescence intensity when photobleaching for 2.5 seconds.
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Future Directions
Since the trend of decreased intensity was observed in almost all of the
pharmacological agents used in the time-lapse imaging assays, we want to examine
these results further. In order to accomplish this, we will use all of the
pharmacological agents in the time-lapse assay during FRAP. Before this can be
done, we must determine the best way to collect FRAP data. One possibility is
changing the shape of the ROI while using the fast tornado parameters. By increasing
the size of the ROI, it is possible to consistently create a rectangular-shaped
photobleach, similar to the black intensity profile in Figure 21. Although this would
be at the expense of photobleaching more cytosol, we decided it more beneficial to
have a consistent ROI. If we could photobleach with the same shaped ROI, we could
continue to push temporal resolution. This would allow us to examine recovery after
only one second of photobleaching.
Another future direction is focusing on, identifying and finding the
significance of the spots in the endogenous AKAP150 staining. By treating the cells
with all of the pharmacological agents used in the time-lapse imaging assay, we can
compare changes in AKAP150 and actin intensities. This would allow us to
determine if the AKAP150 and actin intensities continue to appear to change
together. These results could help in determining if AKAP150 attaches (directly or
indirectly) to actin. Taking videos of transfected cells without photobleaching will
show what is happening to the spots over time. We could determine if the spots
change intensity without photobleaching and calculate their recovery rate. Then we
could determine if rate of change in the spots is different during photobleaching.
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Lastly, we are interested in the changes in cytosolic calcium after treatment
with the pharmacological agents in the time-lapse imaging assay. This can be
investigated using FURA2-AM in cells transfected with AKAP150-GFP. An
increase in cytosolic calcium can indicate the opening of ion channels, leading to the
secretion of hormone. If we could determine which pharmacological agents
potentially cause opening of ion channels, we could learn more about what causes the
translocation of AKAP150-GFP.
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